Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $1.51 billion. The enterprise value is $1.55 billion.
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 356.51 million shares outstanding. The number of shares has increased by 17.64% in one year.
| Current Share Class | 356.51M |
| Shares Outstanding | 356.51M |
| Shares Change (YoY) | +17.64% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 11.80% |
| Owned by Institutions (%) | 37.54% |
| Float | 189.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 109.28 |
| PS Ratio | 47.84 |
| Forward PS | 15.27 |
| PB Ratio | 74.58 |
| P/TBV Ratio | 706.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 49.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.82, with a Debt / Equity ratio of 4.86.
| Current Ratio | 4.82 |
| Quick Ratio | 3.93 |
| Debt / Equity | 4.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.29 |
Financial Efficiency
Return on equity (ROE) is -1,145.42% and return on invested capital (ROIC) is -80.72%.
| Return on Equity (ROE) | -1,145.42% |
| Return on Assets (ROA) | -42.07% |
| Return on Invested Capital (ROIC) | -80.72% |
| Return on Capital Employed (ROCE) | -76.58% |
| Weighted Average Cost of Capital (WACC) | 9.83% |
| Revenue Per Employee | $197,469 |
| Profits Per Employee | -$2.40M |
| Employee Count | 160 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Precigen has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +221.21% in the last 52 weeks. The beta is 1.07, so Precigen's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +221.21% |
| 50-Day Moving Average | 3.95 |
| 200-Day Moving Average | 3.93 |
| Relative Strength Index (RSI) | 52.53 |
| Average Volume (20 Days) | 3,264,129 |
Short Selling Information
The latest short interest is 39.77 million, so 11.16% of the outstanding shares have been sold short.
| Short Interest | 39.77M |
| Short Previous Month | 39.79M |
| Short % of Shares Out | 11.16% |
| Short % of Float | 20.96% |
| Short Ratio (days to cover) | 9.81 |
Income Statement
In the last 12 months, Precigen had revenue of $31.60 million and -$383.42 million in losses. Loss per share was -$1.17.
| Revenue | 31.60M |
| Gross Profit | -11.18M |
| Operating Income | -90.00M |
| Pretax Income | -204.42M |
| Net Income | -383.42M |
| EBITDA | -86.33M |
| EBIT | -90.00M |
| Loss Per Share | -$1.17 |
Full Income StatementBalance Sheet
The company has $56.25 million in cash and $98.25 million in debt, with a net cash position of -$42.00 million or -$0.12 per share.
| Cash & Cash Equivalents | 56.25M |
| Total Debt | 98.25M |
| Net Cash | -42.00M |
| Net Cash Per Share | -$0.12 |
| Equity (Book Value) | 20.24M |
| Book Value Per Share | 0.06 |
| Working Capital | 80.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$115.33 million and capital expenditures -$1.63 million, giving a free cash flow of -$116.96 million.
| Operating Cash Flow | -115.33M |
| Capital Expenditures | -1.63M |
| Depreciation & Amortization | 3.67M |
| Net Borrowing | 92.82M |
| Free Cash Flow | -116.96M |
| FCF Per Share | -$0.33 |
Full Cash Flow StatementMargins
| Gross Margin | -35.39% |
| Operating Margin | -284.85% |
| Pretax Margin | -646.99% |
| Profit Margin | n/a |
| EBITDA Margin | -273.24% |
| EBIT Margin | -284.85% |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.64% |
| Shareholder Yield | -17.64% |
| Earnings Yield | -25.36% |
| FCF Yield | -7.74% |
Analyst Forecast
The average price target for Precigen is $11.00, which is 159.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.00 |
| Price Target Difference | 159.43% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 78.46% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -19.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.91 |
| Piotroski F-Score | 4 |
